Thomas Spector
14Patents
4h-index
12Co-inventors
57Inventor score
Filing activity: Mar 5, 1987 → Oct 14, 2010
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US4758572A | Antiviral combinations | Chemistry; Metallurgy | 8 | Expired |
| US6177436A | Pharmaceutical compositions of 5-alkynyl uracil compounds | Chemistry; Metallurgy | 6 | Expired |
| US5643913A | Pharmaceutical compositions of 5-substituted uracil compounds | Human Necessities | 5 | Expired |
| US5817664A | Uracil reductase inactivators | Chemistry; Metallurgy | 4 | Expired |
| US5393883A | Antiviral combinations and compounds therefor | Human Necessities | 3 | Expired |
| US6268374A | Uracil reductase inactivators | Chemistry; Metallurgy | 2 | Expired |
| US6586440B2 | Pharmaceutical compositions of 5-alkynyl uracil compounds | Chemistry; Metallurgy | 2 | Expired |
| US6297223A | Uracil reductase inactivatores | Chemistry; Metallurgy | 2 | Expired |
| US5175165A | Antiviral combinations and compounds therefor | Human Necessities | 2 | Expired |
| US6221852A | Pharmaceutical compositions of 5-alkynyl-dideoxyribouracil | Chemistry; Metallurgy | 2 | Expired |
| US7119096B2 | Uracil reductase inactivators | Chemistry; Metallurgy | 1 | Expired |
| US8318756B2 | Methods for administering DPD inhibitors in combination with 5-FU and 5-FU prodrugs | Human Necessities | 0 | Expired |
| US7704971B2 | Uracil reductase inactivators | Chemistry; Metallurgy | 0 | Active |
| US8658618B2 | Methods for preventing or reducing neurotoxicity associated with administering DPD inhibitors in combination with 5-FU and 5-FU prodrugs | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.